Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
Related Posts
Publication: Aeroplane wing, a new recessive autosomal phenotypic marker in malaria vector, Anopheles stephensi Liston
Aeroplane wing, a new recessive autosomal phenotypic marker in malaria vector, Anopheles... read more
TIGS and DBT – Centre for DNA Fingerprinting and Diagnostics (CDFD) sign MoU to work on Rare Genetic Disorders
The prevalence of rare genetic disorders (RGDs) in India — home to... read more
PhD Admissions – List of shortlisted candidates
List of shortlisted candidates for TIGS PhD admissions (Jan 2023) via AcSIR... read more
OneHealth national agenda meeting
A meeting at Indian Institute for Science (IISc), involving various academic, research... read more
Quick sequencing offers a better chance at COVID control
The SARS-CoV-2 virus has an opportunity to change every time it replicates... read more
Press Release: Researchers Unveil Detailed Genome of Malaria Mosquito Vector
New ‘gold standard’ reference genome reveals thousands of new genes vital for... read more
SMART Summit 2025 – It’s a Wrap!
✨ The SMART Summit 2025, a one-day event brought together clinicians, researchers,... read more
Ignoring wastewater is a wasted opportunity to improve disease response
During the COVID-19 pandemic, wastewater surveillance emerged as a valuable tool to... read more
TIGS and CSIR – North East Institute Of Science And Technology (NEIST) ink MoU
In the face of climate change, research on plant disease diagnostics, AMR... read more